Literature DB >> 22902478

The crystal structures of TrkA and TrkB suggest key regions for achieving selective inhibition.

T Bertrand1, M Kothe, J Liu, A Dupuy, A Rak, P F Berne, S Davis, T Gladysheva, C Valtre, J Y Crenne, M Mathieu.   

Abstract

The Trk family of neurotrophin receptors, which includes the three highly homologous proteins TrkA, TrkB and TrkC, is strongly associated with central and peripheral nervous system processes. Trk proteins are also of interest in oncology, since Trk activation has been observed in several cancer types. While Trk kinases are attractive oncology targets, selectivity might be more of an issue than for other kinases due to potential CNS side effects if several Trk kinases are simultaneously targeted. In order to address this issue, we present here the first structures of human TrkA and TrkB kinase domains and three complexes between TrkB and Trk inhibitors. These structures reveal different conformations of the kinase domain and suggest new regions of selectivity among the Trk family.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22902478     DOI: 10.1016/j.jmb.2012.08.002

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  33 in total

Review 1.  Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.

Authors:  Subrata Pramanik; Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.590

2.  Genomic subtyping and therapeutic targeting of acute erythroleukemia.

Authors:  Ilaria Iacobucci; Ji Wen; Manja Meggendorfer; John K Choi; Lei Shi; Stanley B Pounds; Catherine L Carmichael; Katherine E Masih; Sarah M Morris; R Coleman Lindsley; Laura J Janke; Thomas B Alexander; Guangchun Song; Chunxu Qu; Yongjin Li; Debbie Payne-Turner; Daisuke Tomizawa; Nobutaka Kiyokawa; Marcus Valentine; Virginia Valentine; Giuseppe Basso; Franco Locatelli; Eric J Enemark; Shirley K Y Kham; Allen E J Yeoh; Xiaotu Ma; Xin Zhou; Edgar Sioson; Michael Rusch; Rhonda E Ries; Elliot Stieglitz; Stephen P Hunger; Andrew H Wei; L Bik To; Ian D Lewis; Richard J D'Andrea; Benjamin T Kile; Anna L Brown; Hamish S Scott; Christopher N Hahn; Paula Marlton; Deqing Pei; Cheng Cheng; Mignon L Loh; Benjamin L Ebert; Soheil Meshinchi; Torsten Haferlach; Charles G Mullighan
Journal:  Nat Genet       Date:  2019-03-29       Impact factor: 38.330

Review 3.  Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling.

Authors:  Hsueh-Liang Fu; Rajeshwari R Valiathan; Richard Arkwright; Anjum Sohail; Cosmin Mihai; Malika Kumarasiri; Kiran V Mahasenan; Shahriar Mobashery; Paul Huang; Gunjan Agarwal; Rafael Fridman
Journal:  J Biol Chem       Date:  2013-01-18       Impact factor: 5.157

4.  Impairment of kindling development in phospholipase Cγ1 heterozygous mice.

Authors:  Xiao Ping He; Renren Wen; James O McNamara
Journal:  Epilepsia       Date:  2014-02-06       Impact factor: 5.864

5.  Structural basis of the transmembrane domain dimerization and rotation in the activation mechanism of the TRKA receptor by nerve growth factor.

Authors:  María L Franco; Kirill D Nadezhdin; Sergey A Goncharuk; Konstantin S Mineev; Alexander S Arseniev; Marçal Vilar
Journal:  J Biol Chem       Date:  2019-12-04       Impact factor: 5.157

6.  Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells.

Authors:  Samuel Lawn; Niveditha Krishna; Alexandra Pisklakova; Xiaotao Qu; David A Fenstermacher; Michelle Fournier; Frank D Vrionis; Nam Tran; Jennifer A Chan; Rajappa S Kenchappa; Peter A Forsyth
Journal:  J Biol Chem       Date:  2014-12-23       Impact factor: 5.157

7.  Structural characterization of nonactive site, TrkA-selective kinase inhibitors.

Authors:  Hua-Poo Su; Keith Rickert; Christine Burlein; Kartik Narayan; Marina Bukhtiyarova; Danielle M Hurzy; Craig A Stump; Xufang Zhang; John Reid; Alicja Krasowska-Zoladek; Srivanya Tummala; Jennifer M Shipman; Maria Kornienko; Peter A Lemaire; Daniel Krosky; Amanda Heller; Abdelghani Achab; Chad Chamberlin; Peter Saradjian; Berengere Sauvagnat; Xianshu Yang; Michael R Ziebell; Elliott Nickbarg; John M Sanders; Mark T Bilodeau; Steven S Carroll; Kevin J Lumb; Stephen M Soisson; Darrell A Henze; Andrew J Cooke
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-30       Impact factor: 11.205

Review 8.  The insulin receptor: both a prototypical and atypical receptor tyrosine kinase.

Authors:  Stevan R Hubbard
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

9.  Comparison of tyrosine kinase domain properties for the neurotrophin receptors TrkA and TrkB.

Authors:  Stephen C Artim; Anatoly Kiyatkin; Mark A Lemmon
Journal:  Biochem J       Date:  2020-10-30       Impact factor: 3.857

10.  Bisphosphonate-Linked TrkB Agonist: Cochlea-Targeted Delivery of a Neurotrophic Agent as a Strategy for the Treatment of Hearing Loss.

Authors:  Judith S Kempfle; Kim Nguyen; Christine Hamadani; Nicholas Koen; Albert S Edge; Boris A Kashemirov; David H Jung; Charles E McKenna
Journal:  Bioconjug Chem       Date:  2018-02-27       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.